Profil
Arunesh Verma is currently President at Fresenius Kabi USA LLC since 2024.
Formerly, Mr. Verma was Chief Executive Officer & Director at Cipla USA, Inc. and Chief Executive Officer at InvaGen Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Mumbai and a graduate degree from Symbiosis Institute of Business Management.
Postes actifs de Arunesh Verma
| Sociétés | Poste | Début |
|---|---|---|
Fresenius Kabi USA LLC
Fresenius Kabi USA LLC Pharmaceuticals: MajorHealth Technology Provides healthcare products and services | President | 10/07/2024 |
Anciens postes connus de Arunesh Verma
| Sociétés | Poste | Fin |
|---|---|---|
InvaGen Pharmaceuticals, Inc.
InvaGen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic prescription medicines | Directeur Général | - |
Cipla USA, Inc.
Cipla USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Formation de Arunesh Verma
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InvaGen Pharmaceuticals, Inc.
InvaGen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic prescription medicines | Health Technology |
Fresenius Kabi USA LLC
Fresenius Kabi USA LLC Pharmaceuticals: MajorHealth Technology Provides healthcare products and services | Health Technology |
Symbiosis Institute of Business Management
Symbiosis Institute of Business Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cipla USA, Inc.
Cipla USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
















